IP Library Granted Patent US 7,709,439
Granted Patent B2
US 7,709,439 · App. 10/781,932 · Granted May 4, 2010

Biomaterials for enhanced healing

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,709,439
App. No.
10/781,932
Granted
May 4, 2010
Kind
B2
Abstract

The present invention relates to novel biomaterials and methods of using these new biomaterials to facilitate wound healing. The novel biomaterial may be a biocompatible polymer to which at least one bioactive polymer is covalently bonded by graft polymerization, copolymerization or cross-linking. Alternatively, the novel biomaterial may be a polymer blend comprising at least one biocompatible polymer and at least one bioactive polymer.

Claims (35)

1. A synthetic biomaterial comprising:

a bioactive polymer comprised of at least one peptide and/or protein subunit and at least one polysaccharide and/or proteoglycan subunit; and

a biocompatible polymer that is different from said bioactive polymer,

wherein the peptide and/or protein subunit of the bioactive polymer is a cell adhesion peptide, wherein the cell adhesion peptide is dRGD peptide, a YIGSR peptide (SEQ ID NO: 16) or a IVKAV peptide (SEQ ID NO: 20), and the at least one peptide and/or protein subunit is covalently bonded to the at least one polysaccharide and/or proteoglycan subunit, and wherein the biocompatible polymer and the bioactive polymer are a miscible polymer blend.

2. A synthetic biomaterial comprising:

a bioactive polymer comprised of at least one peptide and/or protein subunit and at least one polysaccharide and/or proteoglycan subunit; and

a biocompatible polymer,

wherein the peptide and/or protein subunit of the bioactive polymer is a cell adhesion peptide and wherein the cell adhesion peptide is dRGD peptide, a YIGSR peptide (SEQ ID NO: 16) or a IVKAV peptide (SEQ ID NO: 20), and the at least one peptide and/or protein subunit is covalently bonded to the at least one polysaccharide and/or proteoglycan subunit and wherein the biocompatible polymer and the bioactive polymer are an immiscible polymer blend.

3. A synthetic biomaterial comprising:

a bioactive polymer comprised of at least one peptide and/or protein subunit and at least one polysaccharide and/or proteoglycan subunit; and

a biocompatible polymer that is different from said bioactive polymer;

wherein the bioactive polymer and the biocompatible polymer are crosslinked, and the at least one peptide and/or protein subunit is covalently bonded to the at least one polysaccharide and/or proteoglycan subunit.

4. A synthetic biomaterial comprising a graft polymer of:

a bioactive polymer comprising a polysaccharide and/or proteoglycan subunit and a peptide and/or protein subunit;

a biocompatible polymer that is different from said bioactive polymer;

wherein the polysaccharide and/or proteoglycan subunit is covalently bonded to the biocompatible polymer.

5. A synthetic biomaterial comprising:

a bioactive polymer consisting of at least one peptide and/or protein subunit and at least one polysaccharide and/or proteoglycan subunit; and

a biocompatible polymer that is different from said bioactive polymer, wherein the peptide and/or protein subunit of the bioactive polymer is a cell adhesion peptide and wherein the cell adhesion peptide is a dRGD peptide, YIGSR peptide (SEQ ID NO: 16) or a IVKAV peptide (SEQ ID NO: 20), and the at least peptide and/or protein subunit is covalently bonded to the at least one polysaccharide and/or proteoglycan subunit, and wherein the biocompatible polymer and the bioactive polymer are a miscible polymer blend.

6. A synthetic biomaterial comprising:

a bioactive polymer consisting of at least one peptide and/or protein subunit and at least one polysaccharide and/or proteoglycan subunit; and

a biocompatible polymer that is different from said bioactive polymer;

wherein the bioactive polymer and the biocompatible polymer are crosslinked, and the at least one peptide and/or protein subunit is covalently bonded to the at least one polysaccharide and/or proteoglycan subunit.

7. A synthetic biomaterial comprising a graft polymer of:

a bioactive polymer consisting of a polysaccharide and/or proteoglycan subunit and a peptide and/or protein subunit; and

a biocompatible polymer that is different from said bioactive polymer;

wherein the polysaccharide and/or proteoglycan subunit is covalently bonded to the biocompatible polymer.

8. A synthetic biomaterial comprising:

a bioactive polymer comprised of at least one peptide and/or protein subunit and at least one polysaccharide and/or proteoglycan subunit; and

a biocompatible polymer,

wherein the peptide and/or protein subunit of the bioactive polymer is a cell adhesion peptide and wherein the cell adhesion peptide is a RGD peptide, a dRGD peptide, a YIGSR peptide (SEQ ID NO: 16) or a IVKAV peptide (SEQ ID NO: 20), and the at least one peptide and/or protein subunit is covalently bonded to the at least one polysaccharide and/or proteoglycan subunit, and wherein the biocompatible polymer and the bioactive polymer are an immiscible polymer blend.

9. The biomaterial of claim 3 , wherein the biocompatible polymer is polystyrene-isobutylene-polystyrene, a polyurethane, an ethylene vinyl acetate copolymer, a polyolefin elastomer, a polyamide elastomer, or homopolymer or copolymer comprising a monomer such as isobutylene, butyl acrylate, butyl methacrylate, and combinations thereof.

10. The biomaterial of claim 4 , wherein the biocompatible polymer is polystyrene-isobutylene-polystyrene, a polyurethane, an ethylene vinyl acetate copolymer, a polyolefin elastomer, a polyamide elastomer, or homopolymer or copolymer comprising a monomer such as isobutylene, butyl acrylate, butyl methacrylate, and combinations thereof.

11. The biomaterial of claim 6 , wherein the biocompatible polymer is polystyrene-isobutylene-polystyrene, a polyurethane, an ethylene vinyl acetate copolymer, a polyolefin elastomer, a polyamide elastomer, or homopolymer or copolymer comprising a monomer such as isobutylene, butyl acrylate, butyl methacrylate, and combinations thereof.

12. The biomaterial of claim 7 , wherein the biocompatible polymer is polystyrene-isobutylene-polystyrene, a polyurethane, an ethylene vinyl acetate copolymer, a polyolefin elastomer, a polyamide elastomer, or homopolymer or copolymer comprising a monomer such as isobutylene, butyl acrylate, butyl methacrylate, and combinations thereof.

Assignments (3)
CHANGE OF NAME Recorded Dec 11, 2006
From: SCIMED LIFE SYSTEMS, INC.
To: BOSTON SCIENTIFIC SCIMED, INC.
Reel/Frame 018609/0363 →
CHANGE OF NAME Recorded Nov 6, 2006
From: SCIMED LIFE SYSTEMS, INC.
To: BOSTON SCIENTIFIC SCIMED, INC.
Reel/Frame 018505/0868 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 22, 2004
From: HELMUS, MICHAEL N.; RICHARD, ROBERT; DIXON, MELISSA
To: SCIMED LIFE SYSTEMS, INC.
Reel/Frame 015397/0662 →